Search

James Winkler Phones & Addresses

  • Centennial, CO
  • East Lansing, MI
  • Ann Arbor, MI

Work

Company: Array biopharma inc. Address: 3200 Walnut St, Boulder, CO 80301 Phones: (303) 381-6613 Position: Cto Industries: Medical Laboratories

Professional Records

Medicine Doctors

James Winkler Photo 1

Dr. James V Winkler, Denver CO - MD (Doctor of Medicine)

View page
Specialties:
Emergency Medicine
Address:
800 Washington St Suite 909, Denver, CO 80203
(303) 300-2200 (Phone)
Certifications:
Emergency Medicine, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Missouri / Columbia Campus
Graduated: 1972
Medical School
Rhode Island Hospital
Graduated: 1972
Medical School
Denver Health Medical Center
Graduated: 1972
James Winkler Photo 2

Dr. James R Winkler, Farmington Hills MI - DDS (Doctor of Dental Surgery)

View page
Specialties:
Periodontics
Address:
32910 W 13 Mile Rd, Farmington Hills, MI 48334
(248) 626-6526 (Phone)
Languages:
English
Education:
Medical School
Graduates of Institutions Not Listed As Medical Schools
James Winkler Photo 3

James F. Winkler

View page
Specialties:
Family Medicine
Work:
Cayuga Medical AssociatesJames F Winkler MD
216 Montour St, Montour Falls, NY 14865
(607) 535-2712 (phone), (607) 535-2714 (fax)
Education:
Medical School
SUNY Upstate Medical University
Graduated: 1982
Languages:
English
Description:
Dr. Winkler graduated from the SUNY Upstate Medical University in 1982. He works in Montour Falls, NY and specializes in Family Medicine.
James Winkler Photo 4

James L. Winkler

View page
Specialties:
Family Medicine
Work:
Hale Le'a MedicineHale Lea Medicine
2460 Oka St STE 101A, Kilauea, HI 96754
(808) 828-2885 (phone), (808) 828-0119 (fax)
Languages:
English
French
Spanish
Tagalog
Description:
Mr. Winkler works in Kilauea, HI and specializes in Family Medicine.
James Winkler Photo 5

James Winkler, Denver CO

Work:
Porter Adventist Hospital
800 Washington St, Denver, CO 80203

License Records

Medical Doctor

Address:
800 Washington #909, Denver, CO 80203
License #:
19738 - Expired
Issued Date:
Oct 14, 1975
Renew Date:
Jan 24, 2013
Expiration Date:
Apr 30, 2013
Type:
Physician

James Cole Winkler

Address:
4090 Estes St, Wheat Ridge, CO 80033
License #:
12495 - Expired
Issued Date:
Feb 9, 1974
Renew Date:
Jun 1, 1998
Expiration Date:
Jun 1, 1998
Type:
Professional Engineer

James M Winkler

License #:
16831 - Active
Category:
Dual Towing Operator(IM)/VSF Employee
Expiration Date:
Dec 1, 2017

Lawyers & Attorneys

James Winkler Photo 6

James Winkler - Lawyer

View page
Office:
Littler Mendelson P.C.
Specialties:
Legal Ethics and Professional Responsibility
Litigation
Labor Management Relations
Wage and Hour Law
Discrimination and Harassment
Policies, Procedures and Handbooks
ISLN:
902690255
Admitted:
1972
University:
University of Arizona, B.S., 1968
Law School:
Hastings College of Law, University of California, J.D., 1971
James Winkler Photo 7

James Winkler - Lawyer

View page
Office:
Winkler Kurtz, LLP
Specialties:
Matrimonial Law
Divorce
Family Law
Child Custody
ISLN:
902690279
Admitted:
1977
University:
University of Virginia and State University of New York at Stony Brook, B.A., 1971
Law School:
Albany Law School of Union University, J.D., 1976

Resumes

Resumes

James Winkler Photo 8

Metagenomics Manager

View page
Location:
5103 Acacia Ave, Bethesda, MD 20814
Industry:
Biotechnology
Work:
Lanzatech
Metagenomics Manager

Shell Mar 1, 2016 - Nov 13, 2016
Biodomain Researcher

University of Colorado Boulder Sep 2014 - Mar 1, 2016
Postdoctoral Research Associate

National Taiwan University Aug 2015 - Jan 2016
Fulbright Scholar

Texas A&M University Aug 1, 2009 - May 1, 2014
Graduate Student
Education:
Texas A&M University 2009 - 2014
Doctorates, Doctor of Philosophy, Chemical Engineering
Rice University 2005 - 2009
Bachelors, Bachelor of Science, Chemical Engineering
Skills:
Biofuels
Evolution
Stochastic Modeling
Machine Learning
Java
Hplc
Recombineering
Synthetic Biology
Graph Theory
Statistics
Python
Genetic Engineering
Sql
Database Programming
Matlab
Research
Molecular Biology
Data Analysis
Cell Culture
Simulations
Big Data Analytics
Data Visualization
Interests:
Political Science and Economy
Home Improvement
Shooting
Reading
Sports
Golf
Home Decoration
Mandarin Chinese
Gardening
Outdoors
Electronics
Collecting
Kids
Hiking
Automobiles
Travel
Hobby Electronics and Programming
Investing
Traveling
Languages:
English
Mandarin
James Winkler Photo 9

Video Game Designer

View page
Location:
Denver, CO
Industry:
Computer Games
Work:

Video Game Designer

Wicked Cinder Feb 2010 - Mar 2011
Modeler and Texturer

Pederson Toyota May 2005 - Aug 2005
Service Attendant

Koelbel Library Jun 2001 - Aug 2003
Page
Education:
Westwood College - Denver North 2007 - 2009
Bachelors, Bachelor of Science, Art and Design, Design, Art
Colorado State University 2002 - 2007
Skills:
Photoshop
Character Modeling
Microsoft Office
Css
Modeling
Uv Mapping
Adobe Creative Suite
Illustrator
Zbrush
Texturing
Flash
Html
3D Studio Max
Interests:
Music Composition
Video Games
James Winkler Photo 10

James Winkler

View page
James Winkler Photo 11

West Salem High School

View page
Work:

West Salem High School
James Winkler Photo 12

James Winkler

View page
James Winkler Photo 13

James Winkler

View page
James Winkler Photo 14

James Winkler

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
James Winkler
CTO
Array BioPharma Inc.
Medical Laboratories
3200 Walnut St, Boulder, CO 80301
James Winkler
Director Of Medical Affairs
Dmi Biosciences, Inc.
Pharmaceutical Preparations
1999 N Fitzsimons Pkwy, Denver, CO 80045
Mr. James Winkler
President
Hale Le'a Medicine
Kauai Community Health Alliance
Health & Medical - General
2460 Oka Street, 101A, Kilauea, HI 96754
(808) 828-2885
James Winkler
CTO
Array BioPharma Inc.
Medical Laboratories
3200 Walnut St, Boulder, CO 80301
James Winkler
Director Of Medical Affairs
Dmi Biosciences, Inc.
Pharmaceutical Preparations
1999 N Fitzsimons Pkwy, Denver, CO 80045
James Winkler
Chief Executive Officer
Bienestar Group
Business Services
4860 Chambers Rd, Denver, CO 80239
James E. Winkler
THE MAD RIVER WRESTLING OFFICIALS ASSOCIATION
James Roy Winkler
James Winkler DDS,PHD
Dentists
32910 W 13 Mile Rd, Farmington, MI 48334
(248) 626-6526
James Vernon Winkler
James Winkler MD
Emergency Medicine · Family Doctor
800 Washington St, Denver, CO 80203
(303) 300-2200
James H. Winkler
WINKLER & SONS, LLC

Publications

Isbn (Books And Publications)

Apoptosis and Inflammation

View page
Author

James D. Winkler

ISBN #

0817657959

Us Patents

Test For Rapid Evaluation Of Ischemic States And Kit

View page
US Patent:
6461875, Oct 8, 2002
Filed:
Oct 2, 1998
Appl. No.:
09/165926
Inventors:
David Bar-Or - Englewood CO
Edward Lau - Boulder CO
James V. Winkler - Denver CO
Assignee:
Ischemia Technologies, Inc. - Arvada CO
International Classification:
G01N 33536
US Classification:
436536, 436 86, 436518, 435 4, 435 79, 422 8205, 422 8209
Abstract:
The present invention relates to a rapid method for the detection of ischemic states and to a kit for use in such a method. Provided for is a rapid method of testing for the existence of and quantifying ischemia based upon method of detecting and quantifying the existence of an alteration of the serum protein albumin which occurs following an ischemic event; methods for detecting and quantifying this alteration include evaluating and quantifying the cobalt binding capacity of circulating blood, analysis and measurement of the ability of serum albumin to bind exogenous cobalt, detection and measurement of the presence of copper in a purified albumin sample and use of an immunological assay sepcific to the alterated form of serum albumin which occurs following an ischemic event. Also taught by the present invention is the use of the compound Asp-Ala-His-Lys-R, wherein R is any chemical group capable of being detected when bound to any compound capable of binding to the N-terminus of naturally occurring human albumin (including no additional chemical group), for detection and quantification of an ischemic event.

Test For Rapid Evaluation Of Ischemic States And Kit

View page
US Patent:
6492179, Dec 10, 2002
Filed:
Oct 2, 1998
Appl. No.:
09/165581
Inventors:
David Bar-Or - Englewood CO
Edward Lau - Boulder CO
James V. Winkler - Denver CO
Assignee:
Ischemia Techologies, Inc. - Arvada CO
International Classification:
G01N 3320
US Classification:
436 74, 436 63, 436 73, 436 86, 436 87, 436 88, 436171, 436903, 436904, 436518, 435 4, 435 71, 422 55, 422 66, 422 8205, 422 8209, 422 56, 422 58
Abstract:
The present invention relates to a rapid method for the detection of ischemic states and to a kit for use in such a method. Provided for is a rapid method of testing for the existence of and quantifying ischemia based upon method of detecting and quantifying the existence of an alteration of the serum protein albumin which occurs following an ischemic event; methods for detecting and quantifying this alteration include evaluating and quantifying the cobalt binding capacity of circulating blood, analysis and measurement of the ability of serum albumin to bind exogenous cobalt, detection and measurement of the presence of copper in a purified albumin sample and use of an immunological assay sepcific to the alterated form of serum albumin which occurs following an ischemic event. Also taught by the present invention is the use of the compound Asp-Ala-His-Lys-R, wherein R is any chemical group capable of being detected when bound to any compound capable of binding to the N-terminus of naturally occurring human albumin (including no additional chemical group), for detection and quantification of an ischemic event.

Tests For The Rapid Evaluation Of Ischemic States And Kits

View page
US Patent:
7282369, Oct 16, 2007
Filed:
Apr 15, 2003
Appl. No.:
10/414469
Inventors:
David Bar-Or - Englewood CO, US
Edward Lau - Boulder CO, US
James V Winkler - Denver CO, US
Assignee:
Ischemia Technologies, Inc. - Waltham MA
International Classification:
G01N 33/20
G01N 33/48
G01N 31/00
US Classification:
436 74, 436 17, 436 63
Abstract:
The present invention relates to rapid methods for the detection of ischemic states and to kits for use in such methods. Provided for is a rapid method of testing for and quantifying ischemia based upon methods of detecting and quantifying the existence of an alteration of the serum protein albumin which occurs following an ischemic event; methods for detecting and quantifying this alteration include evaluating and quantifying the cobalt binding capacity of circulating albumin, analysis and measurement of the ability of serum albumin to bind exogenous cobalt, detection and measurement of the presence of endogenous copper in a purified albumin sample and use of an immunological assay specific to the altered form of serum albumin which occurs following an ischemic event. Also taught by the present invention is the detection and measurement of an ischemic event by measuring albumin N-terminal derivatives that arise following an ischemic event, including truncated albumin species lacking one to four N-terminal amino acids or albumin with an acetylated N-terminal Asp residue.

Tests For The Rapid Evaluation Of Ischemic States And Kits

View page
US Patent:
7297544, Nov 20, 2007
Filed:
Apr 15, 2003
Appl. No.:
10/413831
Inventors:
David Bar-Or - Englewood CO, US
Edward Lau - Boulder CO, US
James V. Winkler - Denver CO, US
Assignee:
Ischemia Technologies, Inc. - Waltham MA
International Classification:
G01N 33/53
US Classification:
436 71, 436518, 436536
Abstract:
The present invention relates to rapid methods for the detection of ischemic states and to kits for use in such methods. Provided for is a rapid method of testing for and quantifying ischemia based upon methods of detecting and quantifying the existence of an alteration of the serum protein albumin which occurs following an ischemic event; methods for detecting and quantifying this alteration include evaluating and quantifying the cobalt binding capacity of circulating albumin, analysis and measurement of the ability of serum albumin to bind exogenous cobalt, detection and measurement of the presence of endogenous copper in a purified albumin sample and use of an immunological assay specific to the altered form of serum albumin which occurs following an ischemic event. Also taught by the present invention is the detection and measurement of an ischemic event by measuring albumin N-terminal derivatives that arise following an ischemic event, including truncated albumin species lacking one to four N-terminal amino acids or albumin with an acetylated N-terminal Asp residue.

Tests For The Rapid Evaluation Of Ischemic States And Kits

View page
US Patent:
7449338, Nov 11, 2008
Filed:
Dec 13, 2002
Appl. No.:
10/319263
Inventors:
David Bar-Or - Englewood CO, US
Edward Lau - Boulder CO, US
James V. Winkler - Denver CO, US
Gary Fagan - Broomfield CO, US
Hollie Wayment - Elizabeth CO, US
Assignee:
Ischemia Technologies, Inc. - Waltham MA
International Classification:
G01N 33/48
US Classification:
436 63, 436182
Abstract:
The present invention relates to rapid methods for the detection of ischemic states and to kits for use in such methods. Provided for is a rapid method of testing for and quantifying ischemia based upon methods of detecting and quantifying the existence of an alteration of the serum protein albumin which occurs following an ischemic event; methods for detecting and quantifying this alteration include evaluating and quantifying the cobalt binding capacity of circulating albumin, analysis and measurement of the ability of serum albumin to bind exogenous cobalt, detection and measurement of the presence of endogenous copper in a purified albumin sample and use of an immunological assay specific to the altered form of serum albumin which occurs following an ischemic event. Also taught by the present invention is the detection and measurement of an ischemic event by measuring albumin N-terminal derivatives that arise following an ischemic event, including truncated albumin species lacking one to four N-terminal amino acids or albumin with an acetylated N-terminal Asp residue.

Metal-Binding Compounds And Uses Therefor

View page
US Patent:
8017728, Sep 13, 2011
Filed:
Nov 2, 2009
Appl. No.:
12/610508
Inventors:
David Bar-Or - Englewood CO, US
C. Gerald Curtis - Cardiff, GB
Edward Lau - Boulder CO, US
Nagaraja K. R. Rao - Cardiff, GB
James V. Winkler - Denver CO, US
Wannell M. Crook - Castle Rock CO, US
International Classification:
C07K 7/00
US Classification:
530327, 514 215, 514 216, 530328
Abstract:
The invention provides a method of reducing the damage done by reactive oxygen species (ROS) in an animal. The invention also provides a method of reducing the concentration of a metal in an animal. These methods comprise administering to the animal an effective amount of a metal-binding compound as further described in the application. The invention further provides a method of reducing the damage done by ROS to a cell, a tissue or an organ that has been removed from an animal. This method comprising contacting the cell, tissue or organ with a solution or medium containing an effective amount of a metal-binding compound of the invention. The invention further provides novel metal-binding compounds, pharmaceutical compositions comprising the metal-binding compounds, and kits comprising a container holding a metal-binding compound of the invention.

Metal-Binding Compounds And Uses Therefor

View page
US Patent:
20030060408, Mar 27, 2003
Filed:
Feb 13, 2002
Appl. No.:
10/076071
Inventors:
David Bar-Or - Englewood CO, US
C. Curtis - Cardiff, GB
Edward Lau - Boulder CO, US
Nagaraja Rao - Cardiff, GB
James Winkler - Denver CO, US
Wannell Crook - Castle Rock CO, US
International Classification:
A61K038/00
C07K005/00
C07K007/00
C07K016/00
C07K017/00
US Classification:
514/012000, 530/324000
Abstract:
The invention provides a method of reducing the damage done by reactive oxygen species (ROS) in an animal. The invention also provides a method of reducing the concentration of a metal in an animal. These methods comprise administering to the animal an effective amount of a metal-binding compound as further described in the application. The invention further provides a method of reducing the damage done by ROS to a cell, a tissue or an organ that has been removed from an animal. This method comprising contacting the cell, tissue or organ with a solution or medium containing an effective amount of a metal-binding compound of the invention. The invention further provides novel metal-binding compounds, pharmaceutical compositions comprising the metal-binding compounds, and kits comprising a container holding a metal-binding compound of the invention.

Metal-Binding Compounds And Uses Therefor

View page
US Patent:
20030130185, Jul 10, 2003
Filed:
Jun 27, 2002
Appl. No.:
10/186168
Inventors:
David Bar-Or - Englewood CO, US
C. Curtis - Penylan, GB
Edward Lau - Boulder CO, US
Nagaraja Rao - Cardiff, GB
James Winkler - Denver CO, US
Wannell Crook - Castle Rock CO, US
International Classification:
A61K038/10
A61K038/08
US Classification:
514/012000, 514/016000, 514/017000, 514/018000
Abstract:
The invention provides a method of reducing the damage done by reactive oxygen species (ROS) in an animal. The invention also provides a method of reducing the concentration of a metal in an animal. These methods comprise administering to the animal an effective amount of a metal-binding compound as further described in the application. The invention further provides a method of reducing the damage done by ROS to a cell, a tissue or an organ that has been removed from an animal. This method comprising contacting the cell, tissue or organ with a solution or medium containing an effective amount of a metal-binding compound of the invention. The invention further provides novel metal-binding compounds, pharmaceutical compositions comprising the metal-binding compounds, and kits comprising a container holding a metal-binding compound of the invention.
James W Winkler from Centennial, CO, age ~40 Get Report